FDA guidance on prophylactic DNA vaccines: Analysis and recommendations

Dennis M. Klinman; Sven Klaschik; Debra Tross; Hidekazu Shirota; Folkert Steinhagen

doi:10.1016/j.vaccine.2009.11.025

FDA guidance on prophylactic DNA vaccines: Analysis and recommendations

Dennis M. Klinman, Sven Klaschik, Debra Tross, Hidekazu Shirota, Folkert Steinhagen

Research output: Contribution to journal › Comment/debate › peer-review

51 Citations (Scopus)

Abstract

The FDA has been regulating the conduct of prophylactic DNA vaccine trials in the US for nearly 15 years. This work describes the evolution of FDA policy over that period, the status of current regulatory guidance, and provides recommendations for further changes to facilitate development in this field.

Original language	English
Pages (from-to)	2801-2805
Number of pages	5
Journal	Vaccine
Volume	28
Issue number	16
DOIs	https://doi.org/10.1016/j.vaccine.2009.11.025
Publication status	Published - 2010 Apr 1
Externally published	Yes

Keywords

Clinical trials
DNA vaccines
Guidance

ASJC Scopus subject areas

Molecular Medicine
Immunology and Microbiology(all)
veterinary(all)
Public Health, Environmental and Occupational Health
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2009.11.025

Cite this

@article{5ed8d028bb8b41679542505f0a923f90,

title = "FDA guidance on prophylactic DNA vaccines: Analysis and recommendations",

abstract = "The FDA has been regulating the conduct of prophylactic DNA vaccine trials in the US for nearly 15 years. This work describes the evolution of FDA policy over that period, the status of current regulatory guidance, and provides recommendations for further changes to facilitate development in this field.",

keywords = "Clinical trials, DNA vaccines, Guidance",

author = "Klinman, {Dennis M.} and Sven Klaschik and Debra Tross and Hidekazu Shirota and Folkert Steinhagen",

year = "2010",

month = apr,

day = "1",

doi = "10.1016/j.vaccine.2009.11.025",

language = "English",

volume = "28",

pages = "2801--2805",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "16",

}

TY - JOUR

T1 - FDA guidance on prophylactic DNA vaccines

T2 - Analysis and recommendations

AU - Klinman, Dennis M.

AU - Klaschik, Sven

AU - Tross, Debra

AU - Shirota, Hidekazu

AU - Steinhagen, Folkert

PY - 2010/4/1

Y1 - 2010/4/1

N2 - The FDA has been regulating the conduct of prophylactic DNA vaccine trials in the US for nearly 15 years. This work describes the evolution of FDA policy over that period, the status of current regulatory guidance, and provides recommendations for further changes to facilitate development in this field.

AB - The FDA has been regulating the conduct of prophylactic DNA vaccine trials in the US for nearly 15 years. This work describes the evolution of FDA policy over that period, the status of current regulatory guidance, and provides recommendations for further changes to facilitate development in this field.

KW - Clinical trials

KW - DNA vaccines

KW - Guidance

UR - http://www.scopus.com/inward/record.url?scp=77949772876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949772876&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.11.025

DO - 10.1016/j.vaccine.2009.11.025

M3 - Comment/debate

C2 - 19941989

AN - SCOPUS:77949772876

VL - 28

SP - 2801

EP - 2805

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 16

ER -

FDA guidance on prophylactic DNA vaccines: Analysis and recommendations

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this